Award
Purchase Order #75F40126P00202
Supply Chain Monitoring Services for Infant Formula by Circana, LLC
Buyer
Food and Drug Administration
Award Amount
$243,783.80
Ceiling
$243,783.80
Awarded
September 01, 2026
Period of Performance
Sep 01, 2026 – Aug 31, 2027
Identifier
75F40126P00202
NAICS
541910
This award represents a purchase order contract issued to Circana, LLC, a company specializing in market intelligence and data analytics, tasked with supply chain monitoring for infant formula products. The contract supports efforts to enhance the tracking and oversight of infant formula distribution, ensuring product availability and safety for consumers. The scope of work includes monitoring supply chain activities related to infant formula, providing critical data to assist in managing supply disruptions or shortages. Awarded through a direct purchase under Executive Order 14398, the contract signifies a focused, operational approach to addressing supply challenges in an essential public health sector. While competitive bidding details are not specified, the contract reflects a targeted acquisition to meet urgent monitoring needs. The contract duration covers a one-year period, recently commencing in September 2026 and extending through August 2027, with performance localized in Chicago, Illinois.
Description
EO14398-PURCHASE OF SUPPLY CHAIN MONITORING INFANT FORMULA